ObsEva (NASDAQ:OBSV) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.19) by 105.26 percent. This is a 39.29 percent decrease over losses of $(0.28) per share from the same period last year.
TAAT’s Beyond Alternatives To Launch ‘Jayvees’ Reconstituted Hemp-Based Smokables And CBD Edibles
Beyond Alternatives LLC, a subsidiary of TAAT GLOBAL ALTERNATIVES INC. (OTCQX: TOBAF) (CSE:TAAT) (FRANKFURT: 2TP) will be pursuing additional applications of the company’s proprietary base material in emerging market area